Copyright
©The Author(s) 2022.
World J Clin Oncol. Apr 24, 2022; 13(4): 237-266
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.237
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.237
Organ | Concurrent RT/ChT (55 Gy/20 fx) | Sequential RT/ChT (55 Gy/20 fx) | RT (50-58 Gy/15 fx) | RT (50-60 Gy/15 fx)[138] |
Spinal cord | MD 44 Gy (0.1 cc) | Dmax ≤ 36 | MD 42 Gy (0.1 cc) | MD < 38 Gy |
Esophagus1 | MD < 55 Gy (1 cc) | V42 < 32% | MD < 52 Gy (1 cc) | MD < 50 Gy (1 cc), V45 < 10 cc |
Lungs-GTV | V20 < 35%, MD < 18 Gy | V20 < 25%-30%, MD ≤ 15 Gy | V19 < 35%, MD < 16 Gy | V20 < 30%, V5 < 60%, MD < 20 Gy |
Heart | V30 < 36% | V33 < 25% | D100% < 33 Gy, D67% < 40 Gy, D33% < 52 Gy | MD 63 Gy, V57 < 10 cc |
Great vessels | NA | NA | MD 58 Gy | MD 63 Gy, V57 < 10 cc |
Trachea, carina and main bronchus | NA | NA | MD 58 Gy | MD 63 Gy, V57 < 10cc |
Rib | MD < 63 Gy | NA | V30 < 30 cc | MD 63 Gy; V30 < 30cc |
- Citation: Rodríguez De Dios N, Navarro-Martin A, Cigarral C, Chicas-Sett R, García R, Garcia V, Gonzalez JA, Gonzalo S, Murcia-Mejía M, Robaina R, Sotoca A, Vallejo C, Valtueña G, Couñago F. GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer. World J Clin Oncol 2022; 13(4): 237-266
- URL: https://www.wjgnet.com/2218-4333/full/v13/i4/237.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i4.237